Reduced TFAM gene expression in drug-resistant cells is often associated with mitochondrial biogenesis, and combining doxorubicin (a chemotherapy drug) with quercetin (a known inducer of mitochondrial biogenesis) Drug-resistant osteosarcoma cells can be resensitized to doxorubicin (57). This evidence concerns the gene TFAM and osteosarcoma.